{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T02:01:23Z","timestamp":1774144883768,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.jvs.2020.04.518","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T12:53:21Z","timestamp":1589979201000},"page":"132-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization"],"prefix":"10.1016","volume":"73","author":[{"given":"Ahmed K.","family":"Ghamraoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"II","given":"Joseph J.","family":"Ricotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2020.04.518_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jvs.2015.04.460","article-title":"Results of the ROADSTER multicenter trial of transcarotid stenting with dynamic flow reversal","volume":"62","author":"Kwolek","year":"2015","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.04.518_bib2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejvs.2015.11.002","article-title":"Antiplatelet therapy in carotid artery stenting and carotid endarterectomy in the Asymptomatic Carotid Surgery Trial-2","volume":"51","author":"Huibers","year":"2016","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.04.518_bib3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jvs.2011.07.004","article-title":"Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease: executive summary","volume":"54","author":"Ricotta","year":"2011","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.04.518_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3340\/jkns.2018.0151","article-title":"Variability of platelet reactivity on antiplatelet therapy in neurointervention procedure","volume":"62","author":"Yi","year":"2019","journal-title":"J\u00a0Korean Neurosurg Soc"},{"key":"10.1016\/j.jvs.2020.04.518_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCULATIONAHA.109.853069","article-title":"New P2Y12 inhibitors","volume":"121","author":"Cattaneo","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.04.518_bib6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3340\/jkns.2010.48.4.319","article-title":"Anti-platelet drug resistance in the prediction of thromboembolic complications after neurointervention","volume":"48","author":"Ryu","year":"2010","journal-title":"J\u00a0Korean Neurosurg Soc"},{"key":"10.1016\/j.jvs.2020.04.518_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/neurintsurg-2013-010771","article-title":"Carotid artery stenting outcomes: do they correlate with antiplatelet response assays?","volume":"6","author":"Sorkin","year":"2014","journal-title":"J\u00a0Neurointerv Surg"},{"key":"10.1016\/j.jvs.2020.04.518_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.3174\/ajnr.A1070","article-title":"Dual antiplatelet therapy monitoring for neurointerventional procedures using a point-of-care platelet function test: a single-center experience","volume":"29","author":"Lee","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.jvs.2020.04.518_bib9","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1016\/j.jacc.2013.03.036","article-title":"Platelet responsiveness to clopidogrel treatment after peripheral endovascular procedures: the PRECLOP study: clinical impact and optimal cutoff value of on-treatment high platelet reactivity","volume":"61","author":"Spiliopoulos","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.04.518_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/jth.12538","article-title":"Platelet-reactivity tests identify patients at risk of secondary cardiovascular events: a systematic review and meta-analysis","volume":"12","author":"Wisman","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvs.2020.04.518_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2004.07.007","article-title":"Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting","volume":"115","author":"Angiolillo","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2020.04.518_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1552-6569.2008.00322.x","article-title":"Measurement of antiplatelet inhibition during neurointerventional procedures: the effect of antithrombotic duration and loading dose","volume":"20","author":"Pandya","year":"2010","journal-title":"J\u00a0Neuroimaging"},{"key":"10.1016\/j.jvs.2020.04.518_bib13","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.04.518_bib14","first-page":"1082","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"70","author":"Ibanez","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jvs.2020.04.518_bib15","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/jth.12907","article-title":"High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis","volume":"13","author":"Lemesle","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jvs.2020.04.518_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ahj.2014.06.026","article-title":"Platelet reactivity during ticagrelor maintenance therapy: a patient-level data meta-analysis","volume":"168","author":"Alexopoulos","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2020.04.518_bib17","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.04.518_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2020.04.518_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jacc.2010.10.029","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial","volume":"57","author":"Held","year":"2011","journal-title":"J\u00a0Am Coll of Cardiol"},{"key":"10.1016\/j.jvs.2020.04.518_bib20","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1161\/CIRCULATIONAHA.109.919456","article-title":"Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study","volume":"121","author":"Gurbel","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.04.518_bib21","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/CIRCULATIONAHA.113.002589","article-title":"Stent thrombosis with ticagrelor versus clopidogrel in patients with acute coronary syndromes: an analysis from the prospective, randomized PLATO trial","volume":"128","author":"Steg","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.04.518_bib22","doi-asserted-by":"crossref","first-page":"l2211","DOI":"10.1136\/bmj.l2211","article-title":"Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial","volume":"365","author":"Wang","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2020.04.518_bib23","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.thromres.2013.04.030","article-title":"Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention","volume":"132","author":"Laine","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2020.04.518_bib24","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/09537104.2018.1445836","article-title":"Platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor in comparison to clopidogrel: a retrospective pharmacodynamic analysis","volume":"30","author":"Selhorst","year":"2019","journal-title":"Platelets"},{"key":"10.1016\/j.jvs.2020.04.518_bib25","doi-asserted-by":"crossref","first-page":"e13102","DOI":"10.1111\/eci.13102","article-title":"Platelet reactivity patterns in patients treated with dual antiplatelet therapy","author":"Winter","year":"2019","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jvs.2020.04.518_bib26","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2007.07.053","volume":"50","author":"Cannon","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.04.518_bib27","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.04.518_bib28","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.04.518_bib29","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.surg.2016.06.006","article-title":"Estimation of blood loss is inaccurate and unreliable","volume":"160","author":"Rothermel","year":"2016","journal-title":"Surgery"},{"key":"10.1016\/j.jvs.2020.04.518_bib30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jvs.2018.05.011","article-title":"Transcarotid artery revascularization versus transfemoral carotid artery stenting in the Society for Vascular Surgery Vascular Quality Initiative","volume":"69","author":"Malas","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.04.518_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jvs.2018.09.060","article-title":"A\u00a0multi-institutional analysis of transcarotid artery revascularization compared to carotid endarterectomy","volume":"70","author":"Kashyap","year":"2019","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.04.518_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00000542-200610000-00011","article-title":"Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry","volume":"105","author":"Agarwal","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jvs.2020.04.518_bib33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-9560-5-3","article-title":"Evaluation of the TEG platelet mapping assay in blood donors","volume":"5","author":"Bochsen","year":"2007","journal-title":"Thromb J"},{"key":"10.1016\/j.jvs.2020.04.518_bib34","first-page":"1160","article-title":"Laboratory assessments of therapeutic platelet inhibition in endovascular neurosurgery: comparing results of the VerifyNow P2Y12 assay to thromboelastography with platelet mapping","volume":"129","author":"Corliss","year":"2018","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.jvs.2020.04.518_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.lab.2004.01.011","article-title":"A\u00a0novel modification of the Thrombelastograph assay, isolating platelet function, correlates with optical platelet aggregation","volume":"143","author":"Craft","year":"2004","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jvs.2020.04.518_bib36","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ahj.2010.05.034","article-title":"Adenosine diphosphate-induced platelet-fibrin clot strength: a new thrombelastographic indicator of long-term poststenting ischemic events","volume":"160","author":"Gurbel","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.jvs.2020.04.518_bib37","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jvs.2020.04.518_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.15274\/INR-2014-10094","article-title":"Thromboelastography for monitoring platelet function in unruptured intracranial aneurysm patients undergoing stent placement","volume":"21","author":"Yang","year":"2015","journal-title":"Interv Neuroradiol"},{"key":"10.1016\/j.jvs.2020.04.518_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/neurintsurg-2015-011687","article-title":"Association of thrombelastographic parameters with post-stenting ischemic events","volume":"9","author":"Wang","year":"2017","journal-title":"J\u00a0Neurointerv Surg"},{"key":"10.1016\/j.jvs.2020.04.518_bib40","doi-asserted-by":"crossref","first-page":"e12978","DOI":"10.1097\/MD.0000000000012978","article-title":"Choosing between ticagrelor and clopidogrel following percutaneous coronary intervention: a systematic review and meta-analysis (2007-2017)","volume":"97","author":"Guan","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jvs.2020.04.518_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12872-018-0948-4","article-title":"Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: a meta-analysis","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jvs.2020.04.518_bib42","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.thromres.2015.04.014","article-title":"Selection of P2Y12 antagonist, treatment initiation, and predictors of high on-treatment platelet reactivity in a \"real world\" registry","volume":"135","author":"Motovska","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jvs.2020.04.518_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.ccm.0000528176.81944.67","article-title":"Ticagrelor resistance detected by thromboelastography in cardiac surgery patient","volume":"46","author":"Quidley","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jvs.2020.04.518_bib44","first-page":"85","article-title":"Stent thrombosis in a patient with high on-treatment platelet reactivity despite ticagrelor treatment","volume":"4","author":"Musallam","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jvs.2020.04.518_bib45","doi-asserted-by":"crossref","first-page":"2096181","DOI":"10.1155\/2016\/2096181","article-title":"Stent thrombosis patients with hyporesponsiveness to clopidogrel, prasugrel, and ticagrelor: a case series using short thromboelastography","volume":"2016","author":"Olechowski","year":"2016","journal-title":"Case Rep Med"},{"key":"10.1016\/j.jvs.2020.04.518_bib46","first-page":"205","article-title":"Stent thrombosis secondary to ticagrelor resistance demonstrated by thromboelastography","volume":"6","author":"Suleiman","year":"2016","journal-title":"J\u00a0Cardiol Curr Res"},{"key":"10.1016\/j.jvs.2020.04.518_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ihj.2017.10.012","article-title":"Sub-acute stent thrombosis secondary to ticagrelor resistance\u2014myth or reality!!","volume":"69","author":"Jariwala","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jvs.2020.04.518_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1611688","article-title":"Ticagrelor versus clopidogrel in symptomatic peripheral artery disease","volume":"376","author":"Hiatt","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2020.04.518_bib49","first-page":"555","article-title":"Dyspnoea management in acute coronary syndrome patients treated with ticagrelor","volume":"4","author":"Parodi","year":"2015","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.jvs.2020.04.518_bib50","first-page":"800","article-title":"Comparison of 6-month costs between oral antiplatelet agents following acute coronary syndrome","volume":"24","author":"Kim","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420312519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420312519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:30:25Z","timestamp":1760041825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521420312519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0741521420312519"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2020.04.518","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2020.04.518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the Society for Vascular Surgery. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}